P. Dagostino et al., TETRACYCLINE INHIBITS THE NITRIC-OXIDE SYNTHASE ACTIVITY-INDUCED BY ENDOTOXIN IN CULTURED MURINE MACROPHAGES, European journal of pharmacology, 346(2-3), 1998, pp. 283-290
Here we investigate the effects of tetracycline base and of a semi-syn
thetic tetracycline derivative, doxycycline, on the induction of induc
ible nitric oxide synthase and, hence, on the production of nitric oxi
de (NO) by lipopolysaccharide in J774 macrophage cultured in vitro. Th
e treatment of J774 line with tetracycline base (6.25-250 mu M) or dox
ycycline (5-50 mu M) dose-dependently decreased the lipopolysaccharide
-stimulated (1 mu g/ml) inducible NO synthase activity and, consequent
ly, nitrite formation. For instance, the inhibition was 70% for tetrac
ycline base at 250 mu M and 68% for doxycycline at 50 mu M. The inhibi
tory effect of tetracyclines was due neither to a reduction in the via
bility of the cells, studied as colorimetric -[4,5-dimethylthiazol-2yl
]-2,5-diphenyltetrazolium bromide (MTT) reduction assay, nor to an ind
iscriminate inhibition of total protein synthesis, but to a specific d
ecrease in inducible NO synthase protein content in the cells, as atte
sted by the significant reduction of the expression of inducible NO sy
nthase, assayed by sodium-dodecyl sulphate-polyacrylamide gel electrop
horesis (SDS-PAGE) and Western blot. However, no effect of tetracyclin
es on inducible NO synthase mRNA accumulation could be demonstrated in
lipopolysaccharide-stimulated macrophage line, suggesting that the in
hibitory effect of tetracyclines on NO synthesis involves post-transcr
iptional events. The reduction in lipopolysaccharide-stimulated nitrit
e accumulation produced by tetracyclines was significantly less when t
hey were applied 6 h after lipopolysaccharide and absent 12 h after li
popolysaccharide, indicating that tetracyclines modify an early event
in inducible NO synthase activation operating after mRNA transcription
. The findings presented in this study indicate that the modulation of
NO synthesis is another possible pathway by which tetracyclines may f
unction as anti-inflammatory compounds. (C) 1998 Elsevier Science B.V.